Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chikako Inaba is active.

Publication


Featured researches published by Chikako Inaba.


Journal of Hypertension | 2008

Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.

Shogo Koshikawa; Toshio Nishikimi; Chikako Inaba; Kazumi Akimoto; Hiroaki Matsuoka

Background In this study, we tested the hypothesis that long-term Rho-kinase inhibition would reverse nitro-L-arginine methyl ester-exacerbated nephrosclerosis in spontaneously hypertensive rats and attempted to elucidate the mechanism involved. Methods Five groups (each n = 8) were studied: untreated spontaneously hypertensive rats; nitro-L-arginine methyl ester (50 mg/l in drinking water, for 3 weeks)-treated spontaneously hypertensive rats; nitro-L-arginine methyl ester with fasudil (10 mg/kg/day)-treated spontaneously hypertensive rats; nitro-L-arginine methyl ester for 3 weeks followed by fasudil for 3 weeks-treated spontaneously hypertensive rats (same doses), and nitro-L-arginine methyl ester for 3 weeks followed by untreated for 3 weeks. We examined renal function, blood pressure, histological features, oxidative stress markers, and mRNA expression in the renal cortex. Results Nitro-L-arginine methyl ester-treated spontaneously hypertensive rats had higher blood pressure, proteinuria, and serum creatinine and lower creatinine clearance, urinary NO3/NO2 ratio, and urinary cGMP excretion compared with control spontaneously hypertensive rats (all Ps < 0.05). Nitro-L-arginine methyl ester-treated spontaneously hypertensive rats also had increased free radical metabolites and abnormal morphological findings with increased nicotinamide adenine dinucleotide phosphate oxidase activity, phosphorylation of myosin phosphatase targeting subunit-1, and mRNA expression of RhoA, RhoB, RhoC, collagen I and III, transforming growth factor-β, nicotinamide adenine dinucleotide phosphate subunit, endothelial nitric oxide synthase, plasminogen activator inhibitor, and intercellular adhesion molecule-1 in the renal cortex compared with control spontaneously hypertensive rats. Long-term co-treatment with fasudil slightly improved these indices, but most of them were not statistically significant. Late fasudil treatment significantly improved kidney function, morphological changes, and alterations of mRNA expression in the renal cortex, although late untreated controls did not show any improvement. Conclusion These results suggest that Rho-kinase inhibition partly reverses hypertensive glomerulosclerosis. The renoprotective effect of the Rho-kinase inhibitor may have multiple mechanisms including inhibition of extracellular matrix production, oxidative stress, adhesion molecule production, and antifibrinolysis.


Journal of Hypertension | 2007

Inhibition of Rho-kinase attenuates nephrosclerosis and improves survival in salt-loaded spontaneously hypertensive stroke-prone rats

Toshio Nishikimi; Shogo Koshikawa; Yayoi Ishikawa; Kazumi Akimoto; Chikako Inaba; Kimihiko Ishimura; Hidehiko Ono; Hiroaki Matsuoka


Japanese Circulation Journal-english Edition | 2009

Effects of long-term intravenous administration of adrenomedullin (AM) plus hANP therapy in acute decompensated heart failure: a pilot study.

Toshio Nishikimi; Tsuyoshi Karasawa; Chikako Inaba; Kimihiko Ishimura; Kazuyoshi Tadokoro; Shogo Koshikawa; Fumiki Yoshihara; Noritoshi Nagaya; Hideaki Sakio; Kenji Kangawa; Hiroaki Matsuoka


Circulation | 2009

Effects of Long-Term Intravenous Administration of Adrenomedullin (AM) Plus hANP Therapy in Acute Decompensated Heart Failure

Toshio Nishikimi; Tsuyoshi Karasawa; Chikako Inaba; Kimihiko Ishimura; Kazuyoshi Tadokoro; Shogo Koshikawa; Fumiki Yoshihara; Noritoshi Nagaya; Hideaki Sakio; Kenji Kangawa; Hiroaki Matsuoka


Journal of Cardiac Failure | 2008

Molecular Forms of BNP and ANP and gene expression of processing enzyme in atrium and ventricle in heart failure rat

Kimihiko Ishimura; Toshio Nishikimi; Chikako Inaba; Kazuyoshi Tadokoro; Shogo Koshikawa; Hiroaki Matsuoka; Masashi Ikeda; Masako Matsubara; Naoto Minamino


Journal of Cardiac Failure | 2007

Effects of Intravenous Administration of Adrenomedullin (AM) in Patients with Acute Heart Failure

Chikako Inaba; Toshio Nishikimi; Tsuyoshi Karasawa; Yayoi Ishikawa; Shogo Koshikawa; Hideaki Sakio; Hiroaki Matsuoka; Fumiki Yoshihara; Kenji Kangawa


Japanese Circulation Journal-english Edition | 2007

PJ-514 Adrenomedullin (AM) and Its Receptor Components (CRLR, RAMP2, and RAMP3) in Adipocytes : Its Role in Glucose Uptake and Lipolysis(Lipid disorders-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

Toshio Nishikimi; Yayoi Ishikawa; Chikako Inaba; Shogo Koshikawa; Kimihiko Ihsimura; Fumiki Yoshihara; Kenji Kangawa; Hiroaki Matsuoka


Japanese Circulation Journal-english Edition | 2007

FRS-029 Intravenous Administration of Adrenomedullin (AM) is Effective in Acute Heart Failure as a Therapeutic Drug(Clinical Heart Failure-Pathophysiology and Treatment, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

Toshio Nishikimi; Kimihiko Ishimura; Shogo Koshikawa; Chikako Inaba; Yayoi Ishikawa; Hiroaki Matsuoka; Takeshi Karasawa; Hideaki Sakio; Fumiki Yoshihara; Noritoshi Nagaya; Kenji Kangawa


Japanese Circulation Journal-english Edition | 2007

OE-015 Natriuretic Peptide/Natriuretic Peptide Receptor-A (NPR-A) System Has Inhibitory Effects in Renal Fibrosis in Unilateral Ureteral Obstruction (UUO) Model(Kidney/Renal circulation-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

Yayoi Ishikawa; Toshio Nishikimi; Chikako Inaba; Shogo Koshikawa; Kimihiko Ishimura; Kazuyoshi Tadokoro; Hiroaki Matsuoka


Japanese Circulation Journal-english Edition | 2007

OE-014 Fasudil, a Rho-kinnase Inhibitor, Reverses Renal Injury in L-NAME-Exacerbated Nephrosclerosis in SHR : Importance of the Presence of eNOS/NO/cGMP System(Kidney/Renal circulation-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

Shogo Koshikawa; Toshio Nishikimi; Kimihiko Ishimura; Chikako Inaba; Yayoi Ishikawa; Hiroaki Matsuoka

Collaboration


Dive into the Chikako Inaba's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shogo Koshikawa

Dokkyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fumiki Yoshihara

National Archives and Records Administration

View shared research outputs
Top Co-Authors

Avatar

Noritoshi Nagaya

National Archives and Records Administration

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hideaki Sakio

Dokkyo Medical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge